I. – Any healthcare professional who observes or is aware of an adverse reaction occurring in a recipient of labile blood products shall report it without delay to the haemovigilance and transfusion safety correspondent of the healthcare establishment in which the product was administered. If he is unable to identify it, he will report it to any haemovigilance and transfusion safety correspondent in a blood establishment, who will forward this information to the relevant haemovigilance and transfusion safety correspondent.
II. – The haemovigilance and transfusion safety correspondent of the health establishment in which the product in question was administered carries out the appropriate investigations and examinations in the department concerned. He informs the correspondent of the referring blood establishment and, in consultation with him, draws up an adverse reaction report form for a recipient, a copy of which is placed in the recipient’s medical file.